Perrigo Company plc Stock TEL AVIV STOCK EXCHANGE

Equities

PRGO

IE00BGH1M568

Pharmaceuticals

Delayed TEL AVIV STOCK EXCHANGE 5-day change 1st Jan Change
- ILa -.--% Intraday chart for Perrigo Company plc -2.55% -3.73%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 4.62B 1,696B 6.29B Sales 2025 * 4.83B 1,773B 6.57B Capitalization 4.13B 1,514B 5.62B
Net income 2024 * -74M -27.14B -101M Net income 2025 * 106M 38.88B 144M EV / Sales 2024 * 1.59 x
Net Debt 2024 * 3.21B 1,177B 4.36B Net Debt 2025 * 3.01B 1,105B 4.1B EV / Sales 2025 * 1.48 x
P/E ratio 2024 *
-20.9 x
P/E ratio 2025 *
189 x
Employees -
Yield 2024 *
3.64%
Yield 2025 *
3.87%
Free-Float 99.69%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 55 23-06-29
Director of Finance/CFO 49 22-05-15
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Chairman 55 20-12-14
Director/Board Member 68 17-02-05
Director/Board Member 67 17-02-05
More insiders
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.29 USD
Average target price
39.5 USD
Spread / Average Target
+30.41%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW